Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Elizabeth Kelly

10PUBLICATIONS

57CO-AUTHORS

Nanotoxicology, health and safetyInnate immunityPredictive and prognostic markersSpeciation and extinctionNeonatology

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Jan 06, 2026

Reliability of RSV Antigen Diagnostic Tests in the Presence of Nirsevimab.

Sarah R Sincero, Kelly Ann Mahool, Emma Schaefer

|Dec 10, 2024

Lower Respiratory Tract Infections Following Respiratory Syncytial Virus Monoclonal Antibody Nirsevimab Immunization Versus Placebo: Analysis From a Phase 3 Randomized Clinical Trial (MELODY).

Doug Arbetter, Vancheswaran Gopalakrishnan, Anastasia A Aksyuk

|Aug 29, 2024

Long-Term Safety and Immunogenicity of AZD1222 (ChAdOx1 nCoV-19): 2-Year Follow-Up from a Phase 3 Study.

Kathryn Shoemaker, Karina Soboleva, Angela Branche

|Apr 10, 2024

The genomic evolutionary dynamics and global circulation patterns of respiratory syncytial virus.

Annefleur C Langedijk, Bram Vrancken, Robert Jan Lebbink

|Apr 08, 2024

Author Correction: Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials.

Bahar Ahani, Kevin M Tuffy, Anastasia A Aksyuk

|Jul 19, 2023

Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials.

Bahar Ahani, Kevin M Tuffy, Anastasia A Aksyuk

Pageof 2

Frequent Collaborators

4 joint publications

Michael E Abram

3 joint publications

Ron Dagan

3 joint publications

Anastasia A Aksyuk

3 joint publications

Johnathan D Guest

2 joint publications

Ann Marie Stanley

2 joint publications

Shabir A Madhi

2 joint publications

Benjamin Sparklin

1 joint publications

Kelly McGlinchey

1 joint publications

Saul N Faust

1 joint publications

Adrian B McDermott

Frequent Collaborators

4 joint publications

Michael E Abram

3 joint publications

Ron Dagan

3 joint publications

Anastasia A Aksyuk

3 joint publications

Johnathan D Guest

Top Related Videos

Field Postmortem Rabies Rapid Immunochromatographic Diagnostic Test for Resource-Limited Settings with Further Molecular Applications

Field Postmortem Rabies Rapid Immunochromatographic Diagnostic Test for Resource-Limited Settings with Further Molecular Applications

Published on : Jun 29, 2020

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on : Jan 26, 2019

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on : Jun 19, 2018

See more related videos

Top Related Videos

Field Postmortem Rabies Rapid Immunochromatographic Diagnostic Test for Resource-Limited Settings with Further Molecular Applications

Field Postmortem Rabies Rapid Immunochromatographic Diagnostic Test for Resource-Limited Settings with Further Molecular Applications

Published on : Jun 29, 2020

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on : Jan 26, 2019

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on : Jun 19, 2018

See more related videos